Federica Tomao

Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months

Massimo Bellomi, Daniela Origgi, Francesca Botta, 2018, European Radiology.

Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer.

Ludovico Muzii, Claudia Marchetti, Erlisa Bardhi, 2018, Cancer treatment reviews.

Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?

Ludovico Muzii, P. Benedetti Panici, A. Giancotti, 2019, Gynecologic oncology.